In response to the global transformation of clinical trial models, Decentralized Clinical Trials (DCT) have become a key strategy to improve research efficiency, patient engagement, and trial accessibility. To promote innovation in Taiwan’s clinical research ecosystem, this forum will bring together practical experts from the Asia Pacific region, representatives from international pharmaceutical companies and clinical trial service providers, as well as policymakers from Taiwan’s regulatory agencies. Together, they will explore the recommended model of DCT implementation, international collaboration opportunities, and policy developments shaping the future of clinical research.